No Data
No Data
Here Are Big Pharma's Leading Blockbuster Makers
GSK's Marketing Authorization Application for Blenrep Combinations Accepted for Review in EU
GSK (GSK) said Friday that the European Medicines Agency has accepted for review the marketing authorization application for Blenrep, in combination with bortezomib plus dexamethasone or
Blenrep (Belantamab Mafodotin) Combinations in Multiple Myeloma Application Accepted for Review by the European Medicines Agency
Regulatory submission supported by phase III head-to-head DREAMM-7 and DREAMM-8 trialsTrials showed significant progression-free survival benefit and positive overall survival trends for Blenrep
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
European equities traded in the US as American depositary receipts were lower late Wednesday morning, falling 1.33% to 1,437.22 on the S&P Europe Select ADR Index.From continental Europe, the
Global Drug Discovery Technologies Market Insights, 2024-2033 - Top 10 Companies Account for 26.61% of the Total Market; AstraZeneca Leads With 5.73% Share, Followed by Merck and GlaxoSmithKline
Unusual Options Activity: GOOG, BKR and Others Attract Market Bets, GOOG V/OI Ratio Reaches 357.1
EST Jul 11th Afternoon Delivery - In the last two hours of trading, 8 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
No Data